Turning Point Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$329.9M

451 transactions

Summary

Turning Point Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $60.2MSales: $71.9M26 insiders

Date	Insider	Type	Value
2022-08-17	Countouriotis Athena(President & CEO)	D	$8.4M
2022-08-17	Sun Brian(SVP & General Counsel)	D	$3.4M
2022-08-17	Hirmand Mohammad(EVP and Chief Medical Officer)	D	$3.1M
2022-08-17	Sabus Steve M(SVP & Chief Commercial Officer)	D	$2.8M
2022-08-17	TOMBESI PAOLO(EVP & Chief Financial Officer)	D	$2.3M
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Countouriotis Athena(President & CEO)	D	—
2022-08-17	Hirmand Mohammad(EVP and Chief Medical Officer)	D	—
2022-08-17	Hirmand Mohammad(EVP and Chief Medical Officer)	D	—
2022-08-17	Hirmand Mohammad(EVP and Chief Medical Officer)	D	—
2022-08-17	Sabus Steve M(SVP & Chief Commercial Officer)	D	—
2022-08-17	Sun Brian(SVP & General Counsel)	D	—
2022-08-17	TOMBESI PAOLO(EVP & Chief Financial Officer)	D	—
2022-08-17	TOMBESI PAOLO(EVP & Chief Financial Officer)	D	—
2022-08-17	Alles Mark J	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Turning Point Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope